CORC

浏览/检索结果: 共31条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Highly Selective Protein Tyrosine Phosphatase Inhibitor, 2,2 ',3,3 '-Tetrabromo-4,4 ',5,5 '-tetrahydroxydiphenylmethane, Ameliorates Type 2 Diabetes Mellitus in BKS db Mice 期刊论文
MOLECULAR PHARMACEUTICS, 2019, 卷号: 16, 期号: 5, 页码: 1839-1850
作者:  Li, Chao;  Luo, Jiao;  Guo, Shuju;  Jia, Xiaoling;  Guo, Chuanlong
收藏  |  浏览/下载:73/0  |  提交时间:2019/08/28
Separate and combined associations of physical activity and obesity with lipid-related indices in non-diabetic and diabetic patients 期刊论文
LIPIDS IN HEALTH AND DISEASE, 2019, 卷号: 18, 期号: 无, 页码: 9
作者:  Zhang, Yongliang;  Yang, Jian;  Ye, Jun;  Guo, Qiao;  Wang, Weimin
收藏  |  浏览/下载:11/0  |  提交时间:2020/05/21
CYC27 Synthetic Derivative of Bromophenol from Red Alga Rhodomela confervoides: Anti-Diabetic Effects of Sensitizing Insulin Signaling Pathways and Modulating RNA Splicing-Associated RBPs 期刊论文
MARINE DRUGS, 2019, 卷号: 17, 期号: 1, 页码: 15
作者:  Luo, Jiao;  Jiang, Bo;  Li, Chao;  Jia, Xiaoling;  Shi, Dayong
收藏  |  浏览/下载:58/0  |  提交时间:2019/08/28
Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice 期刊论文
CARBOHYDRATE POLYMERS, 2018, 卷号: 190, 页码: 77-86
作者:  Yin, Heng;  Liu, Hongtao;  Zheng, Junping;  Yuan, Xubing;  Cheng, Gong
收藏  |  浏览/下载:27/0  |  提交时间:2019/06/20
Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice 期刊论文
CARBOHYDRATE POLYMERS, 2018, 卷号: 190, 页码: 77-86
作者:  Zheng, Junping;  Yuan, Xubing;  Cheng, Gong;  Jiao, Siming;  Feng, Cui
收藏  |  浏览/下载:46/0  |  提交时间:2018/06/11
Polyphenol-enriched extract of Rosa rugosa Thunb regulates lipid metabolism in diabetic rats by activation of AMPK pathway 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2018, 卷号: 100, 期号: 4, 页码: 29-35
作者:  Liu, L (Liu, Liu);  Yasen, M (Yasen, Mireguli);  Tang, D (Tang, Dan);  Ye, JP (Ye, Jianping);  Aisa, HA (Aisa, Haji Akber)
收藏  |  浏览/下载:44/0  |  提交时间:2018/04/13
Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial 期刊论文
CLINICAL CARDIOLOGY, 2018, 卷号: 41, 期号: 9
作者:  Lorenzatti, Alberto J.;  Eliaschewitz, Freddy G.;  Chen, Yundai;  Fialkow, Jonathan;  Lu, Juming
收藏  |  浏览/下载:14/0  |  提交时间:2019/12/05
Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor 期刊论文
BRITISH JOURNAL OF PHARMACOLOGY, 2018, 卷号: 175, 期号: 1, 页码: 140-153
作者:  Luo, Jiao;  Xu, Qi;  Jiang, Bo;  Zhang, Renshuai;  Jia, Xiaoling
收藏  |  浏览/下载:43/0  |  提交时间:2019/08/20
The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China 期刊论文
PLOS ONE, 2018, 卷号: Vol.13 No.10
作者:  Li, Yaru;  Zhao, Liyun;  Yu, Dongmei;  Ding, Gangqiang
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/26
Discovery of cycloalkyl-fused N-thiazol-2-yl-benzamides as tissue non-specific glucokinase activators: Design, synthesis, and biological evaluation 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 139, 页码: 128-152
作者:  Wang, Zhengyu;  Shi, Xiaofan;  Zhang, Huan;  Yu, Liang;  Cheng, Yanhua
收藏  |  浏览/下载:33/0  |  提交时间:2019/01/08


©版权所有 ©2017 CSpace - Powered by CSpace